Brokerages Set Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Price Target at $41.44
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price […]
